InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: sulaco post# 268996

Monday, 07/25/2016 11:01:22 PM

Monday, July 25, 2016 11:01:22 PM

Post# of 345700
Sulaco, great post and sounds to me like some are not welcoming change in the landscape of Big Pharma... like with PS Targeting about to pick up a percentage of the profits, but more importantly... helping Billions of people.

PS Targeting is a coming ... ready or not for those that though Fargo could have forced Peregrine off the road, and even Garnick knew it was only a bump in the road.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News